Unethical studies on Chinese minority groups are being retracted — but not fast enough, critics say
By Dyani Lewis,
Nature
| 01. 24. 2024
Yves Moreau thought something was amiss when he came across a genetics paper about Tibetans in China. In the 2022 report in PLoS ONE, a team of researchers had collected blood samples from hundreds of people in the Tibet Autonomous Region of China and recorded genetic markers on their X chromosomes. The researchers concluded that this analysis was useful for forensic identification and paternity testing1.
The paper raised immediate red flags for Moreau. Over the past half-decade Moreau, who is a computational geneticist at the Catholic University of Leuven in Belgium, has become deeply concerned about the ethics of studies that report the collection of biometric data from vulnerable or oppressed groups of people2.
n this case, he worried that Chinese security forces might have been involved in the work. One concern was that the blood was collected by being blotted onto reference cards — a method of choice for police forces. Moreover, in 2022, the international advocacy organization Human Rights Watch, among others, had reported that a mass DNA-collection programme of Tibetan populations was...
Related Articles
By Anumita Kaur [cites CGS’ Katie Hasson], The Washington Post | 03.25.2025
Genetic information company 23andMe has said that it is headed to bankruptcy court, raising questions for what happens to the DNA shared by millions of people with the company via saliva test kits.
Sunday’s announcement clears the way for a new...
By Peter Wehling, Tino Plümecke, and Isabelle Bartram
| 03.26.2025
This article was originally published as “Soziogenomik und polygene Scores” in issue 272 (February 2025) of the German-language journal Gen-ethischer Informationsdienst (GID); translated by the authors.
In mid-November 2024, the British organization Hope not Hate published its investigative research ‘Inside the Eugenics Revival’. In addition to documentating an active international “race research” network, the investigation also brought to light the existence of a US start-up that offers eugenic embryo selection. Heliospect Genomics aims to enable wealthy couples to...
By Anna Louie Sussman, The New York Times | 03.25.2025
On June 24, 2022, the same day the Supreme Court issued its decision in Dobbs v. Jackson Women’s Health Organization, I received a call from the fertility clinic where I’d been undergoing in vitro fertilization, informing me that seven of...
By Dalton Conley, The New York Times | 03.13.2025
Since Francis Galton coined the phrase “nature versus nurture” 150 years ago, the debate about what makes us who we are has dominated the human sciences.
Do genes determine our destiny, as the hereditarians would say? Or do we enter...